on 04 Apr 2023
Last Applicant/ Owned by
Bernardsville NJ 07924
Serial Number
79324231 filed on 08th Aug 2021
Registration Number
7014599 registered on 04th Apr 2023
Correspondent Address
Jonathan D. Reichman, Esq.
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research and development of pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; research and development of pharmaceutical preparations; pharmaceutical drug development services; providing scientific rese Read More
Research and development of pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; research and development of pharmaceutical preparations; pharmaceutical drug development services; providing scientific research information in the field of pharmaceuticals and molecular biology; research, analysis, and development in the field of pharmaceutical; research and development in the field of bio-therapeutics for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; scientific investigations for medical purposes; pharmaceutical, medical and scientific research, and development; drug development and discovery; scientific and technological services and research relating to the field of pharmaceuticals
Pharmaceuticals, namely, small molecules therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; pharmaceutical and medical preparations and substances for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; medical and pharmaceutical chemical preparations for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; pharmaceutical preparations for RNA targeted therapeutics; therapeutic agents for acting on protein targets that regulate translational control of gene expression
No 79324231
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
14th Aug 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
21st Jul 2023 | FINAL DISPOSITION PROCESSED |
21st Jul 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
04th Jul 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
18th Apr 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
04th Apr 2023 | REGISTERED-PRINCIPAL REGISTER |
04th Apr 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
29th Mar 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
29th Mar 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
04th Mar 2023 | NEW REPRESENTATIVE AT IB RECEIVED |